These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34842494)

  • 1. Model-based computational precision medicine to develop combination therapies for autoimmune diseases.
    Desvaux E; Aussy A; Hubert S; Keime-Guibert F; Blesius A; Soret P; Guedj M; Pers JO; Laigle L; Moingeon P
    Expert Rev Clin Immunol; 2022 Jan; 18(1):47-56. PubMed ID: 34842494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises.
    Laigle L; Chadli L; Moingeon P
    Expert Rev Clin Immunol; 2023 Mar; 19(3):305-314. PubMed ID: 36680799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Applications of artificial intelligence to new drug development].
    Moingeon P
    Ann Pharm Fr; 2021 Sep; 79(5):566-571. PubMed ID: 33529579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence in early drug discovery enabling precision medicine.
    Boniolo F; Dorigatti E; Ohnmacht AJ; Saur D; Schubert B; Menden MP
    Expert Opin Drug Discov; 2021 Sep; 16(9):991-1007. PubMed ID: 34075855
    [No Abstract]   [Full Text] [Related]  

  • 5. Artificial intelligence-enhanced drug design and development: Toward a computational precision medicine.
    Moingeon P; Kuenemann M; Guedj M
    Drug Discov Today; 2022 Jan; 27(1):215-222. PubMed ID: 34555509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics in support of immunotherapy: contribution to model-based precision medicine.
    Nony E; Moingeon P
    Expert Rev Proteomics; 2022 Jan; 19(1):33-42. PubMed ID: 34937491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are innovation and new technologies in precision medicine paving a new era in patients centric care?
    Seyhan AA; Carini C
    J Transl Med; 2019 Apr; 17(1):114. PubMed ID: 30953518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industrializing AI-powered drug discovery: lessons learned from the
    Guedj M; Swindle J; Hamon A; Hubert S; Desvaux E; Laplume J; Xuereb L; Lefebvre C; Haudry Y; Gabarroca C; Aussy A; Laigle L; Dupin-Roger I; Moingeon P
    Expert Opin Drug Discov; 2022 Aug; 17(8):815-824. PubMed ID: 35786124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision medicine in the era of artificial intelligence: implications in chronic disease management.
    Subramanian M; Wojtusciszyn A; Favre L; Boughorbel S; Shan J; Letaief KB; Pitteloud N; Chouchane L
    J Transl Med; 2020 Dec; 18(1):472. PubMed ID: 33298113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utilization of Autoantibodies in Approaches to Precision Health.
    Fritzler MJ; Martinez-Prat L; Choi MY; Mahler M
    Front Immunol; 2018; 9():2682. PubMed ID: 30505311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational models in inflammatory bowel disease.
    Pinton P
    Clin Transl Sci; 2022 Apr; 15(4):824-830. PubMed ID: 35122401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine.
    Sniecinski I; Seghatchian J
    Transfus Apher Sci; 2018 Jun; 57(3):422-424. PubMed ID: 29784537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational precision medicine: an industry perspective.
    Hartl D; de Luca V; Kostikova A; Laramie J; Kennedy S; Ferrero E; Siegel R; Fink M; Ahmed S; Millholland J; Schuhmacher A; Hinder M; Piali L; Roth A
    J Transl Med; 2021 Jun; 19(1):245. PubMed ID: 34090480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision immunoprofiling by image analysis and artificial intelligence.
    Koelzer VH; Sirinukunwattana K; Rittscher J; Mertz KD
    Virchows Arch; 2019 Apr; 474(4):511-522. PubMed ID: 30470933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
    Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
    Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells: the future of autoimmune disease treatment.
    Ryba-Stanisławowska M; Sakowska J; Zieliński M; Ławrynowicz U; Trzonkowski P
    Expert Rev Clin Immunol; 2019 Jul; 15(7):777-789. PubMed ID: 31104510
    [No Abstract]   [Full Text] [Related]  

  • 18. Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision Oncology.
    Patel SK; George B; Rai V
    Front Pharmacol; 2020; 11():1177. PubMed ID: 32903628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using artificial intelligence methods to speed up drug discovery.
    Álvarez-Machancoses Ó; Fernández-Martínez JL
    Expert Opin Drug Discov; 2019 Aug; 14(8):769-777. PubMed ID: 31140873
    [No Abstract]   [Full Text] [Related]  

  • 20. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
    Ahmed Z
    Hum Genomics; 2020 Oct; 14(1):35. PubMed ID: 33008459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.